• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病与癌变中的肠道微生物群:对治疗的启示

Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.

作者信息

Bruner S D, Jobin C

机构信息

Department of Chemistry, University of Florida, Gainesville, Florida, USA.

Department of Medicine, University of Florida, Gainesville, Florida, USA.

出版信息

Clin Pharmacol Ther. 2016 Jun;99(6):585-7. doi: 10.1002/cpt.348. Epub 2016 Feb 19.

DOI:10.1002/cpt.348
PMID:26850686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5065918/
Abstract

Trillions of bacteria inhabit our intestine, forming a community called the microbiota, whose contributions are essential to maintain host homeostasis. Disruption of this normal microbial-host communication network has deleterious consequences for the host and is associated with intestinal pathologies such as inflammatory bowel diseases (IBD) and colorectal cancer (CRC). Here we present key concepts and mechanisms by which bacteria may participate in intestinal pathology, and discuss possible means to therapeutically target the microbiome.

摘要

数万亿细菌栖息在我们的肠道中,形成一个称为微生物群的群落,其作用对于维持宿主的内环境稳定至关重要。这种正常的微生物与宿主通讯网络的破坏会对宿主产生有害影响,并与肠道疾病如炎症性肠病(IBD)和结直肠癌(CRC)相关。在这里,我们介绍了细菌可能参与肠道病理的关键概念和机制,并讨论了针对微生物群进行治疗的可能方法。

相似文献

1
Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.炎症性肠病与癌变中的肠道微生物群:对治疗的启示
Clin Pharmacol Ther. 2016 Jun;99(6):585-7. doi: 10.1002/cpt.348. Epub 2016 Feb 19.
2
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.炎症性肠病和结直肠癌中的微生物群变化:结肠细胞反应的改变
World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121.
3
[Interaction between humans and intestinal bacteria as a determinant for intestinal health : intestinal microbiome and inflammatory bowel diseases].[人类与肠道细菌之间的相互作用作为肠道健康的决定因素:肠道微生物群与炎症性肠病]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Feb;58(2):159-65. doi: 10.1007/s00103-014-2095-0.
4
Gut microbiota imbalance and colorectal cancer.肠道微生物群失衡与结直肠癌。
World J Gastroenterol. 2016 Jan 14;22(2):501-18. doi: 10.3748/wjg.v22.i2.501.
5
METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.肠道微生物群的代谢失调及其生物标志物
Eksp Klin Gastroenterol. 2016 Jul;12(12):6-29.
6
The resilience of the intestinal microbiota influences health and disease.肠道微生物组的弹性影响健康和疾病。
Nat Rev Microbiol. 2017 Oct;15(10):630-638. doi: 10.1038/nrmicro.2017.58. Epub 2017 Jun 19.
7
Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.微生物组与结直肠癌:解析结肠炎相关结直肠癌发展中的宿主-微生物相互作用。
Semin Immunol. 2017 Aug;32:3-13. doi: 10.1016/j.smim.2017.04.003. Epub 2017 May 2.
8
Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.炎症性肠病中噬菌体、微生物与宿主之间的病理和治疗相互作用。
World J Gastroenterol. 2015 Oct 28;21(40):11321-30. doi: 10.3748/wjg.v21.i40.11321.
9
Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer.宿主-微生物群相互作用与慢性炎症和结直肠癌中的肠干细胞。
Expert Rev Clin Immunol. 2013 May;9(5):409-22. doi: 10.1586/eci.13.27.
10
A survey on the developmental intestinal microbiota research in China: The history, funding, and frontiers of gut bacteria.中国肠道微生物群发育研究调查:肠道细菌的历史、资金及前沿领域
J Dig Dis. 2015 Aug;16(8):421-30. doi: 10.1111/1751-2980.12274.

引用本文的文献

1
Gut microbiome influences efficacy of Endostatin combined with PD-1 blockade against colorectal cancer.肠道微生物组影响内皮抑素联合 PD-1 阻断治疗结直肠癌的疗效。
Mol Biomed. 2024 Sep 10;5(1):37. doi: 10.1186/s43556-024-00200-3.
2
Dietary Inflammatory Index and Non-Communicable Disease Risk: A Narrative Review.饮食炎症指数与非传染性疾病风险:叙事性综述。
Nutrients. 2019 Aug 12;11(8):1873. doi: 10.3390/nu11081873.
3
Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics.肠道微生物群:结直肠癌生物治疗的新视角。

本文引用的文献

1
Cancer and the microbiota.癌症与微生物群
Science. 2015 Apr 3;348(6230):80-6. doi: 10.1126/science.aaa4972.
2
Microbial imbalance and intestinal pathologies: connections and contributions.微生物失衡与肠道病理学:关联与贡献
Dis Model Mech. 2014 Oct;7(10):1131-42. doi: 10.1242/dmm.016428.
3
Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis.脆弱拟杆菌破坏黏膜生物学:从共生菌到结肠癌发生
Onco Targets Ther. 2018 Aug 13;11:4797-4810. doi: 10.2147/OTT.S170626. eCollection 2018.
4
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.肠道细菌、病毒和真菌在炎症性肠病发病机制中的作用及治疗方法
Gastroenterology. 2017 Feb;152(2):327-339.e4. doi: 10.1053/j.gastro.2016.10.012. Epub 2016 Oct 18.
J Clin Invest. 2014 Oct;124(10):4166-72. doi: 10.1172/JCI72334. Epub 2014 Aug 8.
4
The microbiome and cancer.微生物组与癌症。
Nat Rev Cancer. 2013 Nov;13(11):800-12. doi: 10.1038/nrc3610. Epub 2013 Oct 17.
5
Escherichia coli induces DNA double-strand breaks in eukaryotic cells.大肠杆菌可诱导真核细胞中的DNA双链断裂。
Science. 2006 Aug 11;313(5788):848-51. doi: 10.1126/science.1127059.